These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36291956)

  • 1. Use of Proton Pump Inhibitors and the Risk for the Development of Gastric Cancers: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions.
    Gong EJ; Bang CS; Kim DK; Lee JJ; Baik GH
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
    Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
    Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
    Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
    J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study.
    Gong EJ; Jung HK; Lee B; Hong J; Kim JW; Shin CM; Youn YH; Lee KJ
    Aliment Pharmacol Ther; 2023 Oct; 58(7):668-677. PubMed ID: 37589510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
    Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
    Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
    Park JH; Song YM; Jung JH; Han K
    Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between proton pump inhibitors use and risk of asthma in Korea: A prevalent new-user cohort study.
    Lim HJ; Oh IS; Noh Y; Yon DK; Shin JY
    Medicine (Baltimore); 2024 Jan; 103(1):e36772. PubMed ID: 38181266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs prevent gastric cancer associated with the use of proton pump inhibitors after
    Arai J; Niikura R; Hayakawa Y; Sato H; Kawahara T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Ikeya T; Arai M; Suzuki N; Tsuji Y; Yamada A; Koike K
    JGH Open; 2021 Jul; 5(7):770-777. PubMed ID: 34263071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
    Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK
    Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after
    Cheung KS; Leung WK
    Oncotarget; 2018 Dec; 9(97):36891-36893. PubMed ID: 30651922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Reduction in Gastric Atrophy after
    Niikura R; Hayakawa Y; Hirata Y; Ogura K; Fujishiro M; Yamada A; Ushiku T; Konishi M; Fukayama M; Koike K
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
    Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
    J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitors Worsen Colorectal Cancer Outcomes in Patients Treated with Bevacizumab.
    Wu CC; Fang CY; Chiou WY; Chen PT; Hsu TW; Hung SK; Liao YT; Hung CS; Tsai JH
    Cancers (Basel); 2024 Oct; 16(19):. PubMed ID: 39409998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated
    Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):493-499. PubMed ID: 31792089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitor Use Increases Pyogenic Liver Abscess Risk: A Nationwide Cohort Study.
    Oh JH; Kang D; Kang W; Guallar E; Cho J; Min YW
    J Neurogastroenterol Motil; 2021 Oct; 27(4):555-564. PubMed ID: 34642276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.